Project Grant RF1AG088052
Award Date
9/15/24
Completion Date
8/31/27
Dollars Obligated
$2.2M
Funding Federal Agency
National Institute of Neurological Disorders and Stroke
Awarding Federal Agency
National Institute on Aging
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This $2,370,000 Project Grant, awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop advanced human pluripotent stem cell (HPSC) tools for studying region-specific pain circuits. The key objectives are: 1) Developing scalable methods to generate region-specific sensory neurons and glial subtypes; 2) Creating and characterizing region-specific somatosensory organoids that mimic the in vivo...
This $5,037,022 project grant from the National Institutes of Health's National Institute of Neurological Disorders and Stroke will support the development of novel single-cell technologies called "Raman2omics" to map pain-associated genes and cells across the lifespan. Funded under the Drug Abuse and Addiction Research Programs, the grant to the Massachusetts General Hospital aims to apply Raman2omics to systematically investigate genes and cells associated with postoperative pain...
This $2,569,851 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Abuse and Addiction Research Programs (CFDA 93.279), supports research to investigate how the PD-L1/PD-1 immune checkpoint pathway controls physiological and pathological pain, as well as opioid analgesia, through neuronal, immune, and glial mechanisms. The project aims to validate the actions of PD-L1 and the checkpoint inhibitor nivolumab on neuroinflammation and...
This $231,000 Project Grant was awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The goal of the research is to determine whether electrical stimulation of distinct subregions within the insula brain structure can differentially modulate sensory and higher-order, integrative aspects of pain processing. The project will leverage rare opportunities to directly...
This $2,068,842 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to identify the role of prefrontal cortical dynorphin neuron activity and dynorphin release in modulating pain-induced negative affect and nociception. The research aims to use ex-vivo electrophysiology and in-vivo calcium imaging in mice to determine how pain influences the activity of...
This $9,237,770 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a research program titled "IMPETUS: Integrated Mechanisms, Phenotypes, and Translational Underpinnings of Chronic Pain After Surgery". The goal is to gain integrated mechanistic insights into peripheral and central biological processes that contribute to chronic post-surgical pain (CPSP) and...
This Project Grant award, totaling $444,125 and awarded by the National Institute of Neurological Disorders and Stroke (NINDS), is funding research under the Drug Use and Addiction Research Programs (CFDA 93.279) to explore the function of the LRRC55 protein in pain transmission. The primary recipient, Duke University, will investigate the role of LRRC55 in regulating ion channels involved in chronic pain, with the goal of identifying novel, non-opioid therapeutic targets to treat pain. Key...
This federal Project Grant award of $1,511,970.00 from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to develop selective GPR34 antagonists for treating neuropathic pain. The award to Saint Louis University aims to identify CNS-active GPR34 antagonists as potential non-opioid-based therapeutics for neuropathic pain, which affects 15-20 million people in the U.S. The research involves...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,314,276 to Emory University to develop and test novel methods for delivering and assessing nociceptive-specific (pain-specific) stimuli in both pain-free individuals and those with fibromyalgia. The project aims to overcome limitations in current experimental pain testing by identifying skin regions devoid of innocuous...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $456,840.00 to The Leland Stanford Junior University to conduct research on the role of pain-facilitating circuits in chronic pain after traumatic brain injury (TBI). The research aims to characterize the functional and electrophysiological changes in descending...